Cardiogenic shock

From Wikipedia, the free encyclopedia
Cardiogenic shock
Ultrasound showing cardiogenic shock due to myocarditis[1]
SpecialtyCardiology
SymptomsFatigue, rapid heartbeat, shortness of breath, hypotension, sweating[2]
CausesHeart attack, myocarditis, endocarditis, certain medications and substances[2]
Risk factorsHeart failure, old age, hypertension[2]

Cardiogenic shock (CS) is a medical emergency resulting from inadequate blood flow due to the dysfunction of the ventricles of the heart.[3][4][5][6][7] Signs of inadequate blood flow include low urine production (<30 mL/hour), cool arms and legs, and altered level of consciousness. People may also have a severely low blood pressure and heart rate.

Causes of cardiogenic shock include cardiomyopathic, arrhythmic, and mechanical. CS is most commonly precipitated by acute myocardial infarction.[8] Cardiogenic shock is a type of circulatory shock, in which there is insufficient blood flow and oxygen supply for biological tissues to meet the metabolic demands for oxygen and nutrients. Cardiogenic shock is defined by sustained low blood pressure with tissue hypoperfusion despite adequate left ventricular filling pressure. People can have combined types of shock. Shock by definition is inadequate blood circulation to the rest of the body, which causes organ damage. Organs do not have enough oxygen delivery, and cannot adequately maintain their cellular metabolism.

Treatment of cardiogenic shock depends on the cause with the initial goals to improve blood flow to the body. This can be done in a number of ways—fluid resuscitation, blood transfusions, vasopressors, and ionotropes. If cardiogenic shock is due to a heart attack, attempts to open the heart's arteries may help. An intra-aortic balloon pump or left ventricular assist device may improve matters until this can be done. Medications that improve the heart's ability to contract (positive inotropes) may help; however it is unclear which is best and at present there is no convincing evidence supporting inotropic or vasodilating therapy to reduce mortality in hemodynamically unstable patients.[9] Norepinephrine may be better if the blood pressure is very low whereas dopamine or dobutamine may be more useful if only slightly low.[10] Cardiogenic shock is a condition that is difficult to fully reverse even with an early diagnosis. With that being said, early initiation of mechanical circulatory support, early percutaneous coronary intervention, inotropes, and heart transplantation may improve outcomes.[11][12][13][14][15] Care is directed to the dysfunctional organs (dialysis for the kidneys, mechanical ventilation for lungs dysfunction).[16]

Mortality rates have been decreasing in the United States. This is likely due to the rapid identification and treatment of the CS. Some studies have suggested that this possibly related to the increased use of coronary reperfusion strategies, like heart stents. Nonetheless, the mortality rates remain high.[17] Multi-organ failure is associated with higher rates of mortality.

Signs and symptoms[]

The presentation is the following:[citation needed]

  • Anxiety, restlessness, altered mental state due to decreased blood flow to the brain and subsequent hypoxia.
  • Low blood pressure due to decrease in cardiac output.
  • A rapid, weak, thready pulse due to decreased circulation combined with tachycardia.
  • Cool, clammy, and mottled skin (cutis marmorata) due to vasoconstriction and subsequent hypoperfusion of the skin.
  • Distended jugular veins due to increased jugular venous pressure.
  • Oliguria (low urine output) due to inadequate blood flow to the kidneys if the condition persists.
  • Rapid and deeper respirations (hyperventilation) due to sympathetic nervous system stimulation and acidosis.
  • Fatigue due to hyperventilation and hypoxia.
  • Absent pulse in fast and abnormal heart rhythms.
  • Pulmonary edema, involving fluid back-up in the lungs due to insufficient pumping of the heart.

Causes[]

Cardiogenic shock is caused by the failure of the heart to pump effectively. It is due to damage to the heart muscle, most often from a heart attack or myocardial contusion.[18] Other causes include abnormal heart rhythms, cardiomyopathy, heart valve problems, ventricular outflow obstruction (i.e. systolic anterior motion (SAM) in hypertrophic cardiomyopathy), or ventriculoseptal defects. It can also be caused by a sudden decompressurization (e.g. in an aircraft), where air bubbles are released into the bloodstream (Henry's law), causing heart failure.[3][4][5][6][7][19][20]

Diagnosis[]

Electrocardiogram[]

An electrocardiogram helps to establish the exact diagnosis and guides treatment, it may reveal:

  • Abnormal heart rhythms, such as bradycardia (slowed heart rate)[citation needed]
  • myocardial infarction (ST-elevation MI, STEMI, is usually more dangerous than non-STEMIs; MIs that affect the ventricles are usually more dangerous than those that affect the atria; those affecting the left side of the heart, especially the left ventricle, are usually more dangerous than those affecting the right side, unless that side is severely compromised)[citation needed]
  • Signs of cardiomyopathy[citation needed]

Echocardiography[]

Echocardiography may show poor ventricular function, signs of PED, rupture of the interventricular septum, an obstructed outflow tract or cardiomyopathy.[citation needed]

  • Ultrasound showing cardiogenic shock due to myocarditis[1]

  • Ultrasound showing cardiogenic shock due to myocarditis[1]

Swan-Ganz catheter[]

The Swan-Ganz catheter or pulmonary artery catheter may assist in the diagnosis by providing information on the hemodynamics.[citation needed]

Biopsy[]

When cardiomyopathy is suspected as the cause of cardiogenic shock, a biopsy of heart muscle may be needed to make a definite diagnosis.[citation needed]

Cardiac index[]

If the cardiac index falls acutely below 2.2 L/min/m2, the person may be in cardiogenic shock.[citation needed]

Treatment[]

Depending on the type of cardiogenic shock, treatment involves infusion of fluids, or in shock refractory to fluids, inotropic medications. In case of an abnormal heart rhythm immediate synchronized cardioversion or anti-arrhythmic agents may be administered, e.g. adenosine.

Positive inotropic agents (such as dobutamine or milrinone), which enhance the heart's pumping capabilities, are used to improve the contractility and correct the low blood pressure. Should that not suffice an intra-aortic balloon pump (which reduces workload for the heart, and improves perfusion of the coronary arteries) or a left ventricular assist device (which augments the pump-function of the heart) can be considered. Mechanical ventilation or ECMO may be used to help stabilize people with severe or refractory cardiogenic shock until they can be given some type of definitive treatment, such as a ventricular assist device.[3][4][5] Finally, as a last resort, if the person is stable enough and otherwise qualifies, heart transplantation, or if not eligible an artificial heart, can be placed. These invasive measures are important tools—more than 50% of patients who do not die immediately due to cardiac arrest from a lethal abnormal heart rhythm and live to reach the hospital (who have usually suffered a severe acute myocardial infarction, which in itself still has a relatively high mortality rate), die within the first 24 hours. The mortality rate for those still living at time of admission who suffer complications (among others, cardiac arrest or further abnormal heart rhythms, heart failure, cardiac tamponade, a ruptured or dissecting aneurysm, or another heart attack) from cardiogenic shock is even worse around 85%, especially without drastic measures such as ventricular assist devices or transplantation.[citation needed]

Cardiogenic shock may be treated with intravenous dobutamine, which acts on β1 receptors of the heart leading to increased contractility and heart rate.[21]

References[]

  1. ^ Jump up to: a b c "UOTW #7 - Ultrasound of the Week". Ultrasound of the Week. 30 June 2014. Retrieved 27 May 2017.
  2. ^ Jump up to: a b c "Cardiogenic shock - Symptoms and causes". Mayo Clinic. Retrieved 22 May 2020.
  3. ^ Jump up to: a b c Rippe, James M.; Irwin, Richard S. (2003). Irwin and Rippe's intensive care medicine. Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0-7817-3548-3. OCLC 53868338.[page needed]
  4. ^ Jump up to: a b c Marino, Paul L. (1998). The ICU book. Baltimore: Williams & Wilkins. ISBN 978-0-683-05565-8. OCLC 300112092.[page needed]
  5. ^ Jump up to: a b c Society of Critical Care Medicine. (2001). Fundamental Critical Care Support. Society of Critical Care Medicine. ISBN 978-0-936145-02-0. OCLC 48632566.[page needed]
  6. ^ Jump up to: a b Textbooks of Internal Medicine Harrison's Principles of Internal Medicine Archived 2012-08-04 at the Wayback Machine 16th Edition, The McGraw-Hill Companies, ISBN 0-07-140235-7Cecil Textbook of Medicine Archived 2010-06-16 at the Wayback Machine by Lee Goldman, Dennis Ausiello, 22nd Edition (2003), W. B. Saunders Company, ISBN 0-7216-9652-XThe Oxford Textbook of Medicine Edited by David A. Warrell, Timothy M. Cox and John D. Firth with Edward J. Benz, Fourth Edition (2003), Oxford University Press, ISBN 0-19-262922-0
  7. ^ Jump up to: a b Shock: An Overview Archived 2017-06-22 at the Wayback Machine PDF by Michael L. Cheatham, MD, Ernest F.J. Block, MD, Howard G. Smith, MD, John T. Promes, MD, Surgical Critical Care Service, Department of Surgical Education, Orlando Regional Medical Center Orlando, Florida
  8. ^ "UpToDate".
  9. ^ Uhlig, Konstantin; Efremov, Ljupcho; Tongers, Jörn; Frantz, Stefan; Mikolajczyk, Rafael; Sedding, Daniel; Schumann, Julia (November 5, 2020). "Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome". The Cochrane Database of Systematic Reviews. 11: CD009669. doi:10.1002/14651858.CD009669.pub4. ISSN 1469-493X. PMC 8094388. PMID 33152122.
  10. ^ Kanter, Joe; Deblieux, Peter (2014). "Pressors and Inotropes". Emergency Medicine Clinics of North America. 32 (4): 823–34. doi:10.1016/j.emc.2014.07.006. PMID 25441037.
  11. ^ Kataja, Anu; Tarvasmäki, Tuukka; Lassus, Johan; Cardoso, Jose; Mebazaa, Alexandre; Køber, Lars; Sionis, Alessandro; Spinar, Jindrich; Carubelli, Valentina; Banaszewski, Marek; Marino, Rossella; Parissis, John; Nieminen, Markku S.; Harjola, Veli-Pekka (2017). "The association of admission blood glucose level with the clinical picture and prognosis in cardiogenic shock – Results from the Card Shock Study". International Journal of Cardiology. 226: 48–52. doi:10.1016/j.ijcard.2016.10.033. hdl:10138/231345. PMID 27788389.
  12. ^ Basir, Mir B.; Schreiber, Theodore L.; Grines, Cindy L.; Dixon, Simon R.; Moses, Jeffrey W.; Maini, Brijeshwar S.; Khandelwal, Akshay K.; Ohman, E. Magnus; O'Neill, William W. (2017). "Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock". The American Journal of Cardiology. 119 (6): 845–851. doi:10.1016/j.amjcard.2016.11.037. PMID 28040188.
  13. ^ Bagate, François; Lellouche, Nicolas; Lim, Pascal; Moutereau, Stephane; Razazi, Keyvan; Carteaux, Guillaume; De Prost, Nicolas; Dubois-Randé, Jean-Luc; Brun-Buisson, Christian; Mekontso Dessap, Armand (2017). "Prognostic Value of Relative Adrenal Insufficiency During Cardiogenic Shock". SHOCK. 47 (1): 86–92. doi:10.1097/SHK.0000000000000710. PMID 27984534. S2CID 3651074.
  14. ^ Vergara, Ruben; Valenti, Renato; Migliorini, Angela; Cerisano, Giampaolo; Carrabba, Nazario; Giurlani, Letizia; Antoniucci, David (2017). "A New Risk Score to Predict Long-Term Cardiac Mortality in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock and Treated with Primary Percutaneous Intervention". The American Journal of Cardiology. 119 (3): 351–354. doi:10.1016/j.amjcard.2016.10.034. PMID 27884422.
  15. ^ Sarswat, Nitasha; Hollenberg, Steven M. (2015). "Cardiogenic Shock". Hospital Practice. 38 (1): 74–83. doi:10.3810/hp.2010.02.281. PMID 20469627. S2CID 32855274.
  16. ^ Simko, Lynn Coletta; Culleiton, Alicia L. (July 2019). "Cardiogenic shock with resultant multiple organ dysfunction syndrome". Nursing Critical Care. 14 (4): 26–33. doi:10.1097/01.CCN.0000565132.49413.54.
  17. ^ "UpToDate".
  18. ^ International Trauma Life Support for Emergency Care Providers (8 ed.). Pearson Education Limited. 2018. pp. 172–173. ISBN 978-1292-17084-8.
  19. ^ Cardiogenic shock Department of Anaesthesia and Intensive Care of The Chinese University of Hong Kong
  20. ^ Introduction to management of shock for junior ICU trainees and medical students Department of Anaesthesia and Intensive Care of The Chinese University of Hong Kong
  21. ^ Rang and Dale's Pharmacology, H. P. Rang, M. M. Dale, J. M. Ritter, R. J. Flower, Churchhill Livingstone, Elsevier, 6th Edition[page needed]

External links[]

Classification
External resources
Retrieved from ""